Showing 111-120 of 355 grants
| Title | Institution | Researcher | Program | Duration | Total Award Amount |
|---|---|---|---|---|---|
| Achieving persistent presentation of self-antigens to reestablish tolerance and prevent autoimmune diabetes | Trustees of Columbia University in the City of New York | Camillo Bechi Genzano | Cures | 01-March-2025 to 29-February-2028 | $253,647.64 |
| Development of Low Cost, High Precision Nano Pumps for Insulin Delivery | Torramics Inc. | Sergey Gimelshein | Improving Lives | 01-March-2023 to 30-April-2027 | $1,493,212.43 |
| Enhancing Tidepool Loop for Unannounced Meals | Tidepool | Brandon Arbiter | Improving Lives | 01-June-2026 to 31-May-2029 | $2,175,732.12 |
| GABP regulation of human beta cell proliferation | The University of Texas Health Science Center at Houston | Richard Cox | Cures | 01-September-2024 to 31-August-2027 | $200,000.00 |
| Relationships Between Executive Function Challenges and Diabetes Technology Use Among Adults with Type 1 Diabetes | The University of North Carolina at Chapel Hill | Rebecca Vitale | Improving Lives | 01-July-2026 to 30-June-2027 | $49,999.80 |
| Structure-switching Proteins for Continuous In Vivo C-peptide Monitoring | The University of North Carolina at Chapel Hill | Netz Arroyo | Cures | 01-October-2026 to 30-September-2029 | $892,203.85 |
| Engineering B Cell–Targeted Microparticles to Induce Regulatory Immunity in Type 1 Diabetes | The University of North Carolina at Chapel Hill | Kristy Ainslie | Cures | 01-April-2026 to 31-March-2027 | $200,000.00 |
| The Development of 3-β-hydroxybutyrate binding protein based electrochemical micro-sensor and its application for CKM system | The University of North Carolina at Chapel Hill | Koji Sode | Improving Lives | 01-October-2022 to 30-September-2026 | $799,999.96 |
| Role of β-cell Golgi dysfunction in Type 1 diabetes pathogenesis | The University of Iowa | Samuel Stephens | Cures | 01-June-2024 to 31-May-2027 | $750,000.00 |
| Engineered Nanoparticles for Beta Cell-Targeted Therapeutics | The University of Chicago | Raghavendra Mirmira | Cures | 01-April-2023 to 31-August-2026 | $897,822.00 |